Search Results - "McPartlan JS"

Heterologous saRNA prime - multivalent protein boost strategy induces broad and durable immunity against SARS-CoV-2 and MERS-CoV.

Authors: Renn D McPartlan JS Banala S et al.

Source: Scientific reports [Sci Rep] 2026 Mar 23; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 23.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate.

Authors: Versteeg, Leroy Adhikari, Rakesh Robinson, Gonteria et al.

Source: PLoS Pathogens. 12/18/2024, Vol. 20 Issue 12, p1-35. 35p.

A novel combined quadrivalent self-amplifying mRNA-LNP vaccine provokes protective immunity against acute and chronic toxoplasmosis in mice.

Authors: Wu, Qinli Zhang, Zhongao Chu, Hongkun et al.

Source: Infectious Diseases of Poverty. 6/23/2025, Vol. 14 Issue 1, p1-15. 15p.

The evolution of lipid nanoparticles: Paving the way for next-generation nucleic acid medicines.

Authors: Lin, Xuan Xiang, Hongguang Wu, Jiong et al.

Source: Asian Journal of Pharmaceutical Sciences. Feb2026, Vol. 21 Issue 1, p1-34. 34p.

CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response.

Authors: Cen, Qingyan Chen, Jianyu Guo, Jiaxin et al.

Source: Journal of Translational Medicine. 3/17/2024, Vol. 22 Issue 1, p1-21. 21p.

Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer.

Authors: Tang, Lirui Que, Haiying Wei, Yuquan et al.

Source: Journal of Hematology & Oncology. 4/17/2025, Vol. 18 Issue 1, p1-37. 37p.

Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.

Authors: Liu, Jiwei Wu, Lei Xie, Anqi et al.

Source: Journal of Nanobiotechnology. 2/6/2025, Vol. 23 Issue 1, p1-27. 27p.

Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy.

Authors: Alshehry Y Liu X Li W et al.

Source: The AAPS journal [AAPS J] 2025 Mar 18; Vol. 27 (3), pp. 66. Date of Electronic Publication: 2025 Mar 18.

Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Investigation of in vitro delivery conditions for self-amplifying mRNA.

Authors: Li W Wang Y Huo YX et al.

Source: Bioprocess and biosystems engineering [Bioprocess Biosyst Eng] 2025 Nov; Vol. 48 (11), pp. 1833-1844. Date of Electronic Publication: 2025 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101088505 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-7605 (Electronic) Linking ISSN: 16157591 NLM ISO Abbreviation: Bioprocess Biosyst Eng Subsets: MEDLINE

Transcriptome Analysis Reveals a Two-Gene Signature Links to Motor Progression and Alterations of Immune Cells in Parkinson's Disease.

Authors: Li, Weimin Shen, Jiaqi Wu, Hao et al.

Source: Journal of Parkinson's Disease. 2023, Vol. 13 Issue 1, p25-38. 14p.

Nanotechnology in vaccine and immunology.

Authors: Sonali Rawat, Amisha Yadav, Monika

Source: Indian Journal of Biochemistry & Biophysics. Dec2022, Vol. 59 Issue 12, p1135-1143. 9p.

mRNA vaccines: Past, present, future.

Authors: Karam, Mia Daoud, Georges

Source: Asian Journal of Pharmaceutical Sciences. Jul2022, Vol. 17 Issue 4, p491-522. 32p.

A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy.

Authors: Yogodzinski, Christopher Arab, Abolfazl Pritchard, Justin R. et al.

Source: Genome Medicine. 10/18/2021, Vol. 13 Issue 1, p1-12. 12p.

Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.

Authors: Wu, Wantao Liu, Yihan Zeng, Shan et al.

Source: Journal of Hematology & Oncology. 10/7/2021, Vol. 14 Issue 1, p1-28. 28p.

Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults.

Authors: Bartley, Jenna M. Cadar, Andreia N. Martin, Dominique E.

Source: Immunological Investigations. Oct2021, Vol. 50 Issue 7, p810-820. 11p.

Clinical and immunological effects of mRNA vaccines in malignant diseases.

Authors: Heine, Annkristin Juranek, Stefan Brossart, Peter

Source: Molecular Cancer. 3/15/2021, Vol. 20 Issue 1, p1-20. 20p.

mRNA vaccine for cancer immunotherapy.

Authors: Miao, Lei Zhang, Yu Huang, Leaf

Source: Molecular Cancer. 2/25/2021, Vol. 20 Issue 1, p1-23. 23p.

Nanoparticle cancer vaccines: Design considerations and recent advances.

Authors: Jingjing Liu Lei Miao Jiying Sui et al.

Source: Asian Journal of Pharmaceutical Sciences. Sep2020, Vol. 15 Issue 5, p576-590. 15p.

Phenotypic screening using large-scale genomic libraries to identify drug targets for the treatment of cancer (Review).

Authors: MITSUO SATO¹ msato@met.nagoya-u.ac.jp

Source: Oncology Letters. Jun2020, Vol. 19 Issue 6, p3617-3626. 10p.

Why imaging data alone is not enough: AI-based integration of imaging, omics, and clinical data.

Authors: Holzinger, Andreas Haibe-Kains, Benjamin Jurisica, Igor

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2019, Vol. 46 Issue 13, p2722-2730. 9p. 1 Diagram.